Clinical Trials
6 trialsNCT05171075 2026-04-17
MAGNOLIA
Anthos Therapeutics, Inc.
Phase 3 Terminated
NCT06861088 2026-02-02
CATIQ P3
Quercis Pharma AG
Phase 3 Recruiting
NCT04731558 2025-02-14
PREPOSTEROUS
Helsinki University Central Hospital
Phase 4 Recruiting
NCT05303818 2022-03-31
Ésquilo
Hospital do Servidor Publico Estadual
Phase 4 Unknown
NCT00312013 2017-03-23
Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer
GlaxoSmithKline
Phase 3 Completed
NCT00966277 2016-12-12
Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients
M.D. Anderson Cancer Center
Phase 4 Completed